Semax 11 mg is a synthetic heptapeptide for research purposes, studied within neuropeptide, cognitive, and neurological research — available in 11 mg per vial.
Externally tested by an independent EU laboratory. Purity ≥ 99% confirmed via HPLC analysis and mass spectrometry. Certificate of Analysis (COA) available per batch number.
Lyophilized powder. Supplied from Dutch stock, shipped with cooling packaging. Ordered before 14:00 — shipped the same day.
⚠ Intended for scientific and laboratory research only. Not for human consumption. By ordering, you confirm you are 18+ and agree to our terms of use.
Semax (Pro7-ACTH(4-7)) is a synthetic heptapeptide analogue of the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. In scientific literature, it is studied in the context of neurotrophic factor expression (BDNF, NGF), dopaminergic and serotonergic neurotransmission, and neuroplasticity research in animal models. Not approved as a medication by the EMA. Peptidera supplies it solely as a research compound.
Semax (Pro7-ACTH(4-7)) is a synthetic heptapeptide analogue of the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. In scientific literature, it is studied in the context of neurotrophic factor expression (BDNF, NGF), dopaminergic and serotonergic neurotransmission, and neuroplasticity research in animal models. Not approved as a medication by the EMA. Peptidera supplies it solely as a research compound.
Specifications
Storage instructions
Download CoA
Choosing a selection results in a full page refresh.
